ARTICLE | Finance
Buyside Tracks
Biotech investor, banker and analyst personnel changes
April 12, 2010 7:00 AM UTC
Robert Essner joined The Carlyle Group as senior advisor to its global healthcare group. He was the Chairman and CEO of Wyeth, which was acquired last year for $68 billion in cash and stock by Pfizer ...